severe in adults and boys are often more affected than girls. 5 Genetic variants have previously been reported to influence either disease susceptibility or gastrointestinal 6 and renal complications. [7] [8] [9] In some molecular studies, it is indicated that genes can have many effects on the HSP phenotype, and heritage can play a role in the heterogeneity of vasculitis. 10, 11 Nitric oxide (NO) was clearly identified as a vasodilator molecule synthesized from the amino acid L-arginine in mammalian vascular endothelial cells. Because of its vasodilator activity, NO leads to increased cyclic guanosine monophosphate (cGMP) in blood vessel wall activating guanylatcyclase and leading to relaxation of smooth muscles in the endothelium. 12 In addition, endothelial nitric oxide synthase (eNOS) protects the endothelium by inhibiting expression of endothelial adhesion molecules on the surface. Preventing the proliferation of vascular smooth muscle plays an important role in the control of vascular tone. 13 Otherwise, both aggregation and adhesion of platelets to NO via cGMP may inhibit the formation of thrombus. Other roles of NO include a significant impact on renal blood flow, autoregulation, and the regulation of glomerular filtration. [14] [15] [16] It is an most important endogenous molecule that organizes endothelium functions as inhibiting platelet aggregation and vascular smooth muscle cell proliferation. 17 It was suggested that inflammatory effect of NO in the vascular damage is caused by immune complexes. 18 G894T, the most common variant of eNOS polymorphism, has been reported to have an effect on vascular endothelium. In this single nucleotide polymorphism, aspartat (Asp) aminoacid is synthased instead of glutamate (Glu) at 298, due to the transformed G into T at the nucleotide position 894 in exon 7. This replacement leads to reduced enzymatic activitiy, proteolytic cleavage and a decrease in nitric oxide bioavailability. As a result, impaired eNOS bioactivity was found to be associated with endothelial dysfunction, faster renal disease progression and pathological changes in blood vessel. 19 In this study, the effect of the most common variant Glu298Asp polimorphism at eNOS isoform, which has a significant impact on endothelial functions of the NOS gene and known with its effects on the vascular system, on individuals with HSP is investigated. For e-NOS G894T (rs 1799983; Glu298Asp) polymorphism genotyping, venous blood samples were collected in ethylenediaminetetraacetic acid (EDTA) containing tubes. Samples were stored at -20 °C until the assay genomic DNA was isolated and purified using the high pure PCR template preperation kit according to the manufacturer's instructions (QIAamp Blood Kit, Qiagen, GmbH, Hilden, Germany). 
PATIENTS AND METHODS

Ninety
Statistical analysis
Statistical analyses were carried out by using the SPSS version 15.0 for Windows software program (SPSS Inc., Chicago, IL, USA). The eNOS genotype and allele frequencies of HSP and the control group were compared using the Fisher exact, two-proportion Z and Chi-square tests. P<0.05 was considered significant for all statistical analyses. Logistic regression analyses were performed to estimate odd ratios (OR) with 95% confidence intervals (CI).
RESULTS
The male sex was 1.79 times higher than the female sex in the HSP group. This difference was considered statistically significant (p<0.05). The mean sex ratio in this study was compatible with the literature data.
In this study, we investigated the association of eNOS G894T polymorphism with HSP. We analyzed a single nucleotide polymorphism in exon 7. Genotype and allele frequencies of eNOS G894T polymorphism among HSP patients and controls are shown in Table 1 . The genotype frequencies of the HSP group for GG (wild type), GT (heterozygous) and TT (mutant) genotypes were found as 57 (60%), 31 (33%) and seven (7.4%), respectively. There were no significant differences between the two groups (p=0.787, p=0.571, p=0.575) by the two-proportion Z statistic test. No significant differences were observed between the HSP and control groups when the allele frequencies were compared by Fisher exact test (OR=1.002, 95% CI; range 0.622-1.612) ( Table 1 ).
The patient group was classified according to the clinical complications of HSP. This classification demonstrated that all patients had skin manifestations including palpable purpura, 66 patients (69%) had joint involvement, 45 patients (47%) had gastrointestinal involvement, while 31 patients (33%) had renal involvement. On the other hand, one group (n=8) was identified for having four manifestations (skin, joint, gastrointestinal, renal). Purpuric rash was present in all patients, so when the patients and controls compared, there was no statistically significant differences in genotype and allele frequencies (p=0.76 OR=1.002, 95% CI; range 0.622-1.612). Genotype and allele frequencies of joint involvement (n=66), gastrointestinal involvement (n=45), renal manifestation (n=31) groups and controls (n=93) were compared. There were no significant difference between the groups (OR=1.403 95% CI; range 0.849-2.318; Table 3) . A relationship was also found when we compared patients with all four involvements with the patient group with other manifestations, except renal involvement (n=87) (OR=12.818 95% CI; range 3.886-42.277, P GG =0.000, P TT =0.000 <0.05) ( Table 4 ). In addition, all comparisons were tested the using logistic regression analysis (Table 5 ). There was no significant relationship in the logistic regression analysis of GG genotype distribution in the patient and control group, odds ratio (OR)=1.422 95% CI; range 0.823-1.926; p=0.787). Heterozygous genotype for the patient and control group was analyzed using logistic regression and no significantly relation was observed (OR=1.146 95% CI; range 0.689-1.724 p=0.571) Data of the TT genotype factor by logistic regression analysis showed no significant differences in the patients and controls (OR=1.002 95% CI; range 0.622-1.612). Comparision of joint involvement between patients and controls by logistic regression analysis also showed no significant association for the GG genotype OR=1.571 95% CI; range 0.945-2.567 p=0.314 and also no significant differences for GT genotype factor OR=1.437 p=0.717. Mutant genotype distribution data showed no significant association OR=1.437 95% CI; range 0.849-2.318 p=0.240. The third comparision was between gastrointestinal systems involvement patients and the control group. Wild type genotype data showed no However, patient with all four involvement significantly had a correlation with high levels of the TT genotype by logistic regression analysis data. Henoch Schönlein purpura patients with purpura, gastrointestinal system, joint, and renal involvement with significant differences for the GG genotype data OR=11.824 95% CI; range 4.876-39.941; p=0.000, and also the TT genotype factor showed significant associated by logistic regression OR=9.682 95% CI; range 2.972-31.541 p=0.001, but there was no significant differences for GT genotype OR=1.712 95% CI; range 0.934-1.612; p=0.473. In addition, comparison of this logistic regression analysis for the patient 
DISCUSSION
Although the primary cause of HSP is unclear, many researchers believe that infection-related immunological processes including upper respiratory tract infections particularly, are more responsible than damage of the immune system. 21 Recent studies have reported that many different genes have an important role for the HSP phenotype. It has been reported that HLA A2, A11, and B35 antigens showed an increased risk for a predisposition to HSP and HSP patients with nephrotic proteinuria had higher HLA-DRB1*13 positivity. 22, 23 Results of Amoli et al. 24 supported the role of HLA B35 in the susceptibility for HSP patient with nephritis. In another study, transforming growth factor-beta (TGF-b) gene C509T polymorphism was associated with HSP. The mutant genotype (-509 TT) was found to be more common in HSP patients than controls. 25 Therefore, it is not interesting that most of these studies were associated with immunogenetics of vasculitis which occurred as a result of the accumulation of immune complexes. 26 Bruce et al. 27 reported that NO was produced in excessive amounts in systemic vasculitis. In many studies, the Glu298Asp genotype and allele frequencies were found to be much higher in Behçet's disease, which is an immune mediated systemic vasculitis. [28] [29] [30] [31] Likewise Heeringa et al. 32 reported that decreased NO production by endothelial cells, in conjunction with increased NO production by inducible nitric oxide synthase-positive inflammatory cells causes renal tissue damage in Wegener's granulomatosis, which is a systemic vasculitis affecting small and medium-sized vessels. In addition, unclear etiopathogenesis of large vessel vasculitis including Takayasu arteritis and giant cell arteritis may be associated with inducible NOS gene polymorphism. 33 Based on these studies, NO may play a role in the mechanism of vasculitis or may have an impact on the clinical progression of vasculitis. However, there are only a few studies about an association between NOS gene and HSP. One of these associations is NOS2A promoter polymorphism, which may play a role in the susceptibility to HSP and the development of nephritis. 34 In an another study from Northwest Spain, a variable number tandem repeat polymorphism in intron 4, a T/C polymorphism at position -786 in the promoter region, and a polymorphism in exon 7 (298Glu/Asp or 5557G/T) of the eNOS gene were studied in a limited number of HSP patients. According to this study, any significant differences have been found in the allele or genotype frequencies for eNOS polymorphisms between HSP patients for the presence of nephritis, or joint and also gastrointestinal manifestations and controls. 35 However, eNOS haplotype association was observed in patients with biopsy-proven giant cell vasculitis, a large blood vessel vasculitis involving mainly elderly people, when compared with matched controls. 36 Association between Glu298Asp gene polymorphism and many renal sequales including end-stage renal disease, [37] [38] glomerulonephritis, 39 diabetic nephropaty, 40 and immunoglobulin A nephropaty 41 have been reported. Serrano et al. 42 suggested that eNOS deficiency may affect the severity of gastrointestinal complications. With reference to studies showing the importance of eNOS gene in the gastrointestinal system, joint and renal diseases, we classified HSP patients according to the clinical symptoms of the disease. We the compared each HSP group separately with the controls. We did not find any differences, except for HSP patients with all sequelaes as skin, joint, gastrointestinal and renal involvements. However we observed an interesting result comparing the patient group having all involvement, and patients with renal manifestations alone (p<0.005), and with the controls (p<0.005). These comparisions showed statistically significant differences. Mutant allel and genotype frequences increased in HSPs with statistically four sequales.
In conclusion, our data showed that HSP does not have an association with eNOS Glu298Asp eNOS Gene in HSP polymorphism. Nonetheless, we conclude that further comprehensive studies in other regions of the eNOS gene may be more useful for revealing the genetic predisposition of this primary cutaneous vasculitis. Therefore, further largescale studies are required to shed light on the potential role of eNOS polymorphisms in HSP.
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